Presentation is loading. Please wait.

Presentation is loading. Please wait.

Characterization of plasmid-mediated AmpC-producing E

Similar presentations


Presentation on theme: "Characterization of plasmid-mediated AmpC-producing E"— Presentation transcript:

1 Characterization of plasmid-mediated AmpC-producing E
Characterization of plasmid-mediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates  S. Börjesson, C. Jernberg, A. Brolund, P. Edquist, M. Finn, A. Landén, B. Olsson-Liljequist, K. Tegmark Wisell, B. Bengtsson, S. Englund  Clinical Microbiology and Infection  Volume 19, Issue 7, Pages E309-E311 (July 2013) DOI: / Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

2 FIG. 1 Dendogram showing the genotypic relatedness of 16 Escherichia coli carrying blaCMY-2 isolates of broiler origin (C) and 17 E. coli carrying blaCMY-2 isolates of human patient origin (H) based on pulsed-field gel electrophoresis. For comparison, Dice coefficient and unweighted pair group method with arithmetic mean cluster analysis was performed, with position tolerance and optimization both set at 1%. The scale bar represents percentage similarity and the vertical dotted line indicates ≥ 80% similarity. Multilocus sequencing type (MLST) was not determined (ND) for isolates of human origin. Chloramphenicol (C), ciprofloxacin (Ci), nalidixic acid (Na), colistin (Cs), florfenicol (Ff), gentamicin (Gm), kanamycin (Km), streptomycin (Sm), sulphamethoxazole (Su), trimethoprim (Tm) and tetracycline (Tc). Clinical Microbiology and Infection  , E309-E311DOI: ( / ) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "Characterization of plasmid-mediated AmpC-producing E"

Similar presentations


Ads by Google